In this report, we describe a unique method of BPF closure using an endobronchial valve that was designed for the palliative treatment of emphysema and is currently in clinical trails across the United States and Europe.1 The valve is made of a central silicone core that is fashioned to drain air and secretions from the distal lung segment, while blocking entry of air, resulting in redirection of airflow away from diseased segments and, in some cases, collapse of the diseased segment and expansion of the more normal adjacent lung. The core is surrounded by a nitinol expandable mesh that anchors the valve within the bronchus. The valve is inserted through the working channel of the bronchoscope using a guided insertion device provided by the manufacturer. Although the valve is designed to be permanent, it can be removed bronchoscopically with little difficulty. Because of its design, we speculated that the valve could be a potential treatment of distal (not endoscopically visible) BPF.